Yasushi Yatabe
#111,472
Most Influential Person Now
Researcher
Yasushi Yatabe's AcademicInfluence.com Rankings
Yasushi Yatabecomputer-science Degrees
Computer Science
#4218
World Rank
#4439
Historical Rank
Computational Linguistics
#360
World Rank
#366
Historical Rank
Machine Learning
#761
World Rank
#772
Historical Rank
Artificial Intelligence
#970
World Rank
#988
Historical Rank
Download Badge
Computer Science
Yasushi Yatabe's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yasushi Yatabe Influential?
(Suggest an Edit or Addition)Yasushi Yatabe's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. (2010) (3811)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (2011) (3193)
- The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. (2015) (2865)
- Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival (2004) (2492)
- Comprehensive genomic profiles of small cell lung cancer (2015) (1397)
- A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. (2005) (1308)
- Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer (2004) (1215)
- EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. (2010) (1142)
- Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. (2005) (938)
- Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. (1998) (897)
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (2018) (669)
- Reduced expression of Dicer associated with poor prognosis in lung cancer patients (2005) (638)
- Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations. (2008) (616)
- Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib (2006) (611)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. (2011) (600)
- Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer (2007) (587)
- A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer (2012) (543)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
- PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 Project (2018) (525)
- Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer (2010) (478)
- The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (2016) (443)
- Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
- Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. (2013) (368)
- Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients (2003) (363)
- Investigating stem cells in human colon by using methylation patterns (2001) (354)
- TTF-1 Expression in Pulmonary Adenocarcinomas (2002) (354)
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer (2011) (340)
- Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. (1999) (339)
- Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. (2006) (310)
- Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis (2013) (300)
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. (2018) (294)
- Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers (2009) (289)
- Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art? (2015) (244)
- Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib (2011) (236)
- EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma (2005) (231)
- Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma (2009) (226)
- Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. (2011) (221)
- Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors. (2010) (219)
- CD74-NRG1 fusions in lung adenocarcinoma. (2014) (212)
- CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. (1997) (207)
- Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer. (2016) (206)
- Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer (2010) (203)
- Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients (2004) (202)
- Biological and clinical implications of EGFR mutations in lung cancer (2006) (201)
- Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA (2009) (199)
- Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study (2012) (196)
- A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. (2006) (192)
- Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. (2009) (190)
- Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. (2010) (183)
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. (2018) (182)
- Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. (2019) (182)
- ABCA transporter gene expression and poor outcome in epithelial ovarian cancer. (2014) (177)
- The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015. (2021) (177)
- The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016. (2016) (174)
- EGFR T790M mutation: a double role in lung cancer cell survival? (2009) (171)
- TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth (2012) (171)
- Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells (1998) (169)
- Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers (2002) (169)
- Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer (2007) (169)
- Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. (2004) (167)
- Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. (2007) (165)
- Genetic reconstruction of individual colorectal tumor histories. (2000) (164)
- PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee. (2019) (163)
- Evaluation of Ki-67 index in EUS–FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors (2013) (162)
- EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs (2015) (160)
- Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR). (2012) (159)
- Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer (2008) (159)
- Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. (1997) (157)
- An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators (2014) (152)
- Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. (2013) (150)
- Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma (2000) (149)
- Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients (2004) (147)
- EGFR Mutation Testing Practices within the Asia Pacific Region (2015) (143)
- Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers. (2011) (139)
- Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study (2017) (136)
- Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. (2008) (135)
- Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to Gefitinib (2009) (132)
- IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY. (2020) (132)
- Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI (2015) (131)
- Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience (2013) (127)
- miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. (2011) (125)
- Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers (2007) (124)
- Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes (1999) (120)
- Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. (2022) (120)
- Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. (1996) (119)
- Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation (2012) (118)
- Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas (2007) (117)
- p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. (1998) (116)
- Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer (2010) (113)
- ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. (2005) (113)
- Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
- Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort (2011) (111)
- Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. (2010) (111)
- Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
- EGFR mutations and the terminal respiratory unit (2010) (107)
- Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. (2004) (106)
- Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society. (2016) (105)
- Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers (2002) (104)
- The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification (2009) (104)
- Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence—first results of an inter‐ethnic breast cancer study (2004) (103)
- Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future (2005) (103)
- Counterbalance between RB inactivation and miR-17–92 overexpression in reactive oxygen species and DNA damage induction in lung cancers (2009) (103)
- Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene. (2012) (102)
- YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation. (2008) (102)
- Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. (2010) (101)
- Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas (2001) (101)
- Do all lung adenocarcinomas follow a stepwise progression? (2011) (100)
- The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases (2017) (100)
- The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee (2020) (97)
- Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32 (2007) (95)
- Expression of CD109 in human cancer (2004) (93)
- Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society. (2016) (92)
- Pulmonary Cysts of Birt-Hogg-Dubé Syndrome: A Clinicopathologic and Immunohistochemical Study of 9 Families (2012) (91)
- Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis. (2018) (91)
- Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. (1996) (91)
- Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib. (2016) (90)
- ABO Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and Helicobacter pylori Infection (2011) (90)
- PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients (2006) (90)
- Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer (2013) (89)
- The Impact of Sex and Smoking Status on the Mutational Spectrum of Epidermal Growth Factor Receptor Gene in Non–small Cell Lung Cancer (2007) (89)
- EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. (2006) (89)
- Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1. (1997) (88)
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
- A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population (2012) (88)
- Risk factors differ for non‐small‐cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case‐control study in Japanese (2007) (88)
- Clinicopathologic study of nasal T/NK‐cell lymphoma among the Japanese (1997) (88)
- Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. (2008) (87)
- CK20 expression, CDX2 expression, K‐ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas (2004) (86)
- Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report (2010) (86)
- A Screening Method for the ALK Fusion Gene in NSCLC (2012) (84)
- Surgery for NSCLC in the era of personalized medicine (2013) (84)
- High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. (2000) (83)
- Epidermal growth factor receptor mutations in lung cancers (2007) (83)
- Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. (2000) (82)
- Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. (1999) (82)
- CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance. (2014) (81)
- Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis (2006) (81)
- How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? (2013) (80)
- A Grading system for invasive pulmonary adenocarcinoma: a proposal from the IASLC pathology committee. (2020) (78)
- The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer. (2013) (78)
- Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells. (2009) (78)
- Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment (2013) (78)
- Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. (2007) (78)
- Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer (2014) (77)
- A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. (2007) (76)
- Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma. (2017) (76)
- Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer (2017) (75)
- Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases (1997) (74)
- HNF4&agr; as a Marker for Invasive Mucinous Adenocarcinoma of the Lung (2013) (74)
- Development of a New Rapid Isolation Device for Circulating Tumor Cells (CTCs) Using 3D Palladium Filter and Its Application for Genetic Analysis (2014) (73)
- Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer (2015) (73)
- The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity. (2014) (72)
- Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. (1997) (72)
- TGF-b synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth (2012) (71)
- Helicobacter pylori and the t(11;18)(q21;q21) Translocation in Gastric Low‐grade B‐Cell Lymphoma of Mucosa‐associated Lymphoid Tissue Type (2000) (71)
- A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee (2020) (69)
- Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis (2013) (69)
- Mutations of epidermal growth factor receptor and K‐ras genes in adenosquamous carcinoma of the lung (2006) (68)
- Tumor Mutation Burden: Promises and Challenges A Perspective from the IASLC Pathology Committee. (2020) (68)
- Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society. (2017) (67)
- Comparison between self‐reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population (2010) (67)
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population (2011) (67)
- The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene status. (2003) (66)
- Inconsistent association of Epstein‐Barr virus with CD56 (NCAM)‐positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract (1996) (65)
- Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. (2012) (64)
- Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma (2016) (63)
- Gene expression profiling of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways (2014) (63)
- Immunocytochemistry for predictive biomarker testing in lung cancer cytology (2019) (63)
- Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas? (2014) (62)
- GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas (2015) (62)
- Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation (2004) (60)
- Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer (2011) (58)
- The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor (R) Descriptors for Non-Small Cell Lung Cancer. (2019) (58)
- Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis (2006) (58)
- Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. (2015) (58)
- EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort (2009) (58)
- Dramatic tumor response to everolimus for malignant epithelioid angiomyolipoma. (2011) (57)
- Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers. (1997) (57)
- Clinical Features and Prognosis of Gastric MALT Lymphoma With Special Reference to Responsiveness to H. pylori Eradication and API2-MALT1 Status (2008) (56)
- Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers (1998) (56)
- High‐level expression of CD109 is frequently detected in lung squamous cell carcinomas (2007) (56)
- Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. (2016) (56)
- RASSF1A gene inactivation in non‐small cell lung cancer and its clinical implication (2003) (55)
- c-Maf Expression in Angioimmunoblastic T-cell Lymphoma (2007) (55)
- Lymphoblastic lymphoma expressing CD56 and TdT. (1998) (55)
- ROS1 Immunohistochemistry Among Major Genotypes of Non—Small-Cell Lung Cancer (2014) (54)
- Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation. (2012) (54)
- Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. (1998) (53)
- Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations (2016) (53)
- Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma (1994) (52)
- Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer. (2011) (51)
- Perforin and granzyme expression in cytotoxic T-cell lymphomas. (1998) (51)
- Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. (1996) (51)
- Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study (2010) (51)
- HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition (2017) (51)
- Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma (2009) (51)
- Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach (2007) (50)
- EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma (2015) (50)
- BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens (2013) (49)
- Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (2007) (49)
- Sentinel lymph node radiolocalization in clinically negative neck oral cancer (2006) (49)
- Establishment of an IL‐2‐dependent cell line derived from ‘nasal‐type’ NK/T‐cell lymphoma of CD2+, sCD3−, CD3ɛ+, CD56+ phenotype and associated with the Epstein‐Barr virus (1998) (49)
- Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas (2011) (49)
- P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation (2012) (48)
- Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy (2009) (47)
- Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese. (2008) (47)
- Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms (2016) (47)
- Interleukin‐2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor‐overexpressing gastric cancer xenografts through antibody‐dependent cellular cytotoxicity (2008) (47)
- miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. (2015) (45)
- Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population (2011) (44)
- Case–case comparison of smoking and alcohol risk associations with Epstein–Barr virus‐positive gastric cancer (2014) (44)
- Morphological spectrum of cyclin D1‐positive mantle cell lymphoma: Study of 168 cases (2001) (44)
- Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments. (2001) (44)
- Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma (2017) (43)
- Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations (2016) (43)
- Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society. (2017) (43)
- Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound‐guided fine needle aspiration (2010) (43)
- Cyclin D1 over expression in malignant lymphomas (1997) (43)
- Association between an 8q24 locus and the risk of colorectal cancer in Japanese (2009) (42)
- Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial. (2017) (42)
- MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma (2017) (42)
- Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer. (2016) (41)
- Impact of age on epidermal growth factor receptor mutation in lung cancer. (2012) (41)
- Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma (2013) (41)
- Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population. (2010) (41)
- Characteristic methylation profile in CpG island methylator phenotype‐negative distal colorectal cancers (2010) (41)
- hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type (2009) (41)
- Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer (2003) (40)
- Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features. (2014) (40)
- Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial (2019) (40)
- Increased expression of COX-2 in the development of human lung cancers. (2002) (40)
- Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11 (2015) (39)
- Scientific Advances in Thoracic Oncology 2016. (2017) (39)
- Transformation to sarcomatoid carcinoma in ALK-rearranged adenocarcinoma, which developed acquired resistance to crizotinib and received subsequent chemotherapies. (2013) (38)
- Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases. (1999) (38)
- Chronic active Epstein-Barr virus infection with giant coronary aneurysms. (1996) (38)
- The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA‐A*3101 and ‐A*3303 (2006) (38)
- Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. (2016) (38)
- Association between a Genome-Wide Association Study-Identified Locus and the Risk of Lung Cancer in Japanese Population (2012) (38)
- Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma (2016) (38)
- Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer. (2010) (37)
- LKB1 gene mutations in Japanese lung cancer patients (2007) (37)
- Current Concept of Endoscopic Ultrasound-Guided Fine Needle Aspiration for Pancreatic Cancer (2011) (37)
- Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. (2015) (35)
- Clinical course of gastrointestinal stromal tumor diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration (2015) (35)
- Pyothorax-associated lymphoma. An unusual case with biphenotypic character of T and B cells. (1996) (35)
- Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma (2008) (35)
- ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers (2016) (35)
- Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. (2009) (34)
- Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small cell lung cancer. (2019) (34)
- Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer (2016) (34)
- Interobserver Agreement in the Nuclear Grading of Primary Pulmonary Adenocarcinoma (2013) (34)
- Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society. (2016) (33)
- Anti‐Helicobacter pylori Antibody Profiles in Epstein‐Barr virus (EBV)‐Positive and EBV‐Negative Gastric Cancer (2016) (33)
- Prognostic models in patients with non‐small‐cell lung cancer using artificial neural networks in comparison with logistic regression (2003) (33)
- ALK FISH and IHC: you cannot have one without the other. (2015) (32)
- Pure acinic cell carcinoma of the breast in an 80‐year‐old Japanese woman (2007) (32)
- Folate, alcohol, and aldehyde dehydrogenase 2 polymorphism and the risk of oral and pharyngeal cancer in Japanese (2012) (32)
- Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA (2021) (31)
- Intraoperative diagnosis of cancer metastasis in sentinel lymph node of oral cancer patients. (2008) (31)
- Colorectal pretumor progression before and after loss of DNA mismatch repair. (2004) (31)
- Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa‐associated lymphoid tissue lymphomas (2007) (31)
- Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long‐term follow‐up study: proposals for follow‐up strategies (2015) (31)
- Somatic Hypermutations in the VH Segment of Immunoglobulin Genes of CDS‐positive Diffuse Large B‐Cell Lymphomas (1997) (31)
- Decreased expression of 14-3-3σ in neuroendocrine tumors is independent of origin and malignant potential (2002) (30)
- PL 03.03 Blueprint 2: PD-L1 Immunohistochemistry Comparability Study in Real-Life, Clinical Samples (2017) (30)
- Intraoperative Molecular Assessment for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma Using One-Step Nucleic Acid Amplification (OSNA) Assay (2012) (30)
- Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients (2011) (30)
- Folate Intake along with Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Thymidylate Synthase in Patients with Advanced Gastric Cancer (2010) (30)
- Role of Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Diagnosing Metastasis to the Pancreas: A Tertiary Center Experience (2011) (30)
- Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma (2012) (29)
- Soy consumption reduces the risk of non‐small‐cell lung cancers with epidermal growth factor receptor mutations among Japanese (2008) (29)
- Estimation of the pathological invasive size of pulmonary adenocarcinoma using high-resolution computed tomography of the chest: A consideration based on lung and mediastinal window settings. (2016) (29)
- Peripheral T/Natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases (2001) (29)
- Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion (2018) (29)
- Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target (2018) (29)
- "Pseudoprogression" of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy. (2016) (29)
- Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor. (2010) (29)
- Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer. (1998) (29)
- Diagnostic yield of endoscopic retrograde cholangiography and of EUS-guided fine needle aspiration sampling in gallbladder carcinomas (2012) (29)
- EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study. (2013) (28)
- Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. (2011) (28)
- Rare pancreatic neoplasms: the utility of endoscopic ultrasound-guided fine-needle aspiration—a large single center study (2009) (28)
- Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately (2019) (27)
- Association Between EGFR T790M Status and Progression Patterns During Initial EGFR‐TKI Treatment in Patients Harboring EGFR Mutation (2017) (27)
- Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer. (2010) (27)
- Cell‐Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis (2016) (27)
- Primary gastric T-cell lymphoma. Morphological and immunohistochemical studies of two cases. (1994) (27)
- Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung (2017) (26)
- Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy (2009) (26)
- ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer. (2022) (26)
- Topographical distributions of allelic loss in individual non-small-cell lung cancers. (2000) (26)
- Primary hepatic marginal zone B-cell lymphoma with mantle cell lymphoma phenotype (1996) (25)
- Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations (2013) (25)
- mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines (2007) (25)
- Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study (2014) (25)
- Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer (2015) (24)
- Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer. (2019) (24)
- Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms. (2014) (24)
- Can Endoscopic Ultrasound-Guided Fine Needle Aspiration Offer Clinical Benefit for Tumors of the Ampulla of Vater? -An Initial Study (2012) (24)
- Inherited lung cancer syndromes targeting never smokers. (2018) (24)
- HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women (2010) (24)
- RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations (2012) (23)
- A novel technique for endoscopic transpapillary "mapping biopsy specimens" of superficial intraductal spread of bile duct carcinoma (with videos). (2014) (23)
- Lung cancers unrelated to smoking: characterized by single oncogene addiction? (2011) (23)
- Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities (2021) (23)
- Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression (2014) (23)
- Peroral cholangioscopy of nivolumab-related (induced) ulcerative cholangitis in a patient with non-small cell lung cancer (2018) (23)
- Significance of cyclin D 1 overexpression for the diagnosis of mantle cell lymphoma : a clinicopathologic comparison of cyclin D 1-positive MCL and cyclin D 1-negative MCL-like B-cell lymphoma (2000) (23)
- Thyroid anaplastic carcinoma transformed from papillary carcinoma in extrathyroid area. (2004) (22)
- Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma (2008) (22)
- Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways. (2010) (22)
- IASLC AtL AS of ALK teStIng In Lung CAnCer (2013) (22)
- Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes (2018) (22)
- A nodal γ/δ T-cell lymphoma with an association of Epstein-Barr virus (1997) (22)
- Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations. (2012) (22)
- Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease. (1996) (21)
- Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients. (2018) (21)
- Fulminant myocarditis demonstrating uncommon morphology—a report of two autopsy cases (2005) (21)
- Association between insulin‐like growth factor‐1 polymorphisms and stomach cancer risk in a Japanese population (2011) (21)
- Distribution of Intraductal Lesions in Small Invasive Ductal Carcinoma of the Pancreas (2007) (20)
- Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. (2018) (20)
- Throwing new light on lung cancer pathogenesis: Updates on three recent topics (2005) (20)
- Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report (2019) (20)
- Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment (2018) (20)
- Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer (2012) (20)
- Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case‐control study (2018) (20)
- Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion. (2008) (20)
- Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs. (2016) (19)
- Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma. (2012) (19)
- Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy (2013) (19)
- Aquaporin 1 water channel is overexpressed in the plasma membranes of pancreatic ducts in patients with autoimmune pancreatitis. (2009) (19)
- Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data. (2004) (19)
- Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis (2015) (18)
- Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy. (2010) (18)
- Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LGL) leukemia. (1994) (18)
- Neuroendocrine tumor metastasis to the thyroid gland (2007) (18)
- High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers (2012) (18)
- In compressed lung tissue microscopic sections of adenocarcinoma in situ may mimic papillary adenocarcinoma. (2013) (17)
- Aberrant expression of interferon regulatory factor 3 in human lung cancer. (2010) (17)
- Multiplex gene‐panel testing for lung cancer patients (2020) (17)
- Is Primary Pulmonary Meningioma a Giant Form of a Meningothelial-Like Nodule? A Case Report and Review of the Literature (2012) (17)
- Histone H1 expression in human prostate cancer tissues and cell lines (2012) (17)
- Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins (2015) (17)
- Absence of the caveolin-1 P132L mutation in cancers of the breast and other organs. (2010) (17)
- The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures. (2018) (17)
- Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure. (2017) (17)
- Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition (2018) (17)
- Rapid and dramatic response to alectinib in an anaplastic lymphoma kinase rearranged non-small-cell lung cancer patient who is critically ill. (2016) (17)
- Impact of intraoperative specimen mammography on margins in breast-conserving surgery. (2016) (17)
- Concurrent Gastric MALT and Hodgkin Lymphoma (2012) (17)
- A Randomized Controlled Trial Evaluating a Low-Volume PEG Solution Plus Ascorbic Acid versus Standard PEG Solution in Bowel Preparation for Colonoscopy (2015) (17)
- Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung. (2021) (17)
- Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement (2018) (17)
- Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: a case report. (2007) (16)
- Characterization of High‐grade Neuroendocrine Tumors of the Lung in Relation to menin Mutations (2000) (16)
- Combined hepatocellular carcinoma and osteoclast‐like giant cell tumor of the liver: Possible clue to histogenesis (2009) (16)
- Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma (2013) (16)
- Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations (2010) (16)
- Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer--from studies of 604 surgical cases. (2007) (16)
- Primary gastric lymphomas: Morphologic, immunohistochemical and immunogenetic analyses (1996) (16)
- Primary low‐grade gastric mucosa‐associated lymphoid tissue (MALT) lymphoma with polypoid appearance. Polypoid gastric MALT lymphoma: A clinicopathologic study of eight cases (1999) (16)
- Clinicopathologic Features of Thymoma With the Expression of Programmed Death Ligand 1. (2019) (15)
- Molecular testing in stage I-III non-small cell lung cancer: Approaches and challenges. (2021) (15)
- Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma (2018) (15)
- Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform (2019) (15)
- Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the IASLC Grading System. (2022) (15)
- Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck (2020) (15)
- Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. (1997) (15)
- Prognostic implication of the EGFR gene mutations in a large cohort of Japanese patients with early stage lung adenocarcinoma (2007) (15)
- Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women. (2019) (15)
- Immunohistochemical study of necrotizing lymphadenitis: A possible mechanism for apoptosis involving perforin and granzyme‐producing cytotoxic T cells (1997) (15)
- Circulating tumor cells detection in tumor draining vein of breast cancer patients (2019) (14)
- Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases (2021) (14)
- Coexistence of primary pulmonary Hodgkin lymphoma and gastric MALT lymphoma associated with Epstein‐Barr virus infection: A case report (2010) (14)
- Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition (2019) (14)
- Primary gastric Hodgkin's disease. Morphologic, immunohistochemical, and immunogenetic analyses. (1995) (14)
- Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan (2019) (14)
- Impact of PSCA Variation on Gastric Ulcer Susceptibility (2013) (14)
- Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women (2012) (14)
- Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non‐small‐cell lung cancer for gefitinib treatment (2009) (14)
- Frameshift mutations in TGFbetaRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancers. (1999) (14)
- Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy (2008) (14)
- TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection (2017) (14)
- Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer (2017) (14)
- A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer (2017) (14)
- Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform. (2018) (14)
- Clinical benefit of endocrine therapy for benign metastasizing leiomyoma (2011) (14)
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation (2008) (14)
- Phenotypic composition of salivary gland tumors: an application of principle component analysis to tissue microarray data (2004) (14)
- Lack of Association between the BIM Deletion Polymorphism and the Risk of Lung Cancer with and without EGFR Mutations (2015) (13)
- Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF (2020) (13)
- Primary gastric Ki‐1 positive anaplastic large cell lymphoma: A report of two cases (1994) (13)
- Bladder cancer genotype stability during clinical progression (2000) (13)
- Effect of gefitinib on the survival of patients with recurrence of lung adenocarcinoma after surgery: a retrospective case-matching cohort study. (2010) (13)
- A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer. (2016) (13)
- Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers (2016) (13)
- The Isoform Matters in NUT Carcinoma: A Diagnostic Pitfall of p40 Immunohistochemistry. (2020) (13)
- Prognostic significance of combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas (2015) (13)
- Saturation transfer ratio imaging in invasive ductal carcinomas of the breast. (2000) (13)
- Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS (2011) (12)
- Frequent expression of CD30 antigen in the primary gastric non‐B, non‐Hodgkin lymphomas (2004) (12)
- Thyroid transcription factor‐1 expression in rare cases of mammary ductal carcinoma (2011) (12)
- Endoscopic features of short-term progression of esophageal intramural pseudodiverticulosis. (2010) (12)
- Controversy about Small Peripheral Lung Adenocarcinomas: How Should We Manage Them? (2007) (12)
- Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (2018) (12)
- Time to first cigarette and lung cancer risk in Japan. (2013) (12)
- Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood. (1995) (12)
- Brief Report: Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel Testing. (2019) (12)
- Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models (2017) (12)
- Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy (2017) (11)
- A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green–Labeled Podoplanin Antibody (2018) (11)
- Natural killer cell leukemia. An autopsy case. (1994) (11)
- Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity. (2014) (11)
- Epithelial hyperplasia of usual type expresses both S100‐α and S100‐β in a heterogeneous pattern but ductal carcinoma in situ can express only S100‐α in a monotonous pattern (1997) (11)
- Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA (2021) (11)
- A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case–control studies (2016) (11)
- Risk of second malignancies in patients with gastric marginal zone lymphomas of mucosa associate lymphoid tissue (MALT) (2014) (11)
- Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer (2014) (11)
- CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation. (2014) (11)
- Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis (2019) (11)
- Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer. (2016) (11)
- Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features (2019) (10)
- Immunohistochemical characteristics of monocytoid B cell lymphoma, mantle zone lymphoma, small lymphocytic lymphoma (or B chronic lymphocytic leukemia), and hairy cell leukemia. (1993) (10)
- Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer. (2017) (10)
- Coincidence of Mammary and Sentinel Lymph Node Papilloma (2008) (10)
- Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy (2016) (10)
- Angioimmunoblastic T-cell lymphoma with autoimmune thrombocytopenia: a report of two cases. (2010) (10)
- Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE‐A and NY‐ESO‐1 expression in adenoid cystic carcinoma (2017) (10)
- Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer. (2018) (10)
- Increased T-cell responses to Epstein–Barr virus with high viral load in patients with Epstein–Barr virus-positive diffuse large B-cell lymphoma (2015) (10)
- First report of a mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) (2012) (10)
- API2‐MALT1 chimeric transcript‐positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years (2007) (10)
- Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (2021) (10)
- Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma. (2017) (9)
- Review of Bioptic Gleason Scores by Central Pathologist Modifies the Risk Classification in Prostate Cancer (2015) (9)
- OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study (2018) (9)
- Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese. (2012) (9)
- The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation (2019) (9)
- P03.02 Neoadjuvant Osimertinib with/without Chemotherapy vs Chemotherapy for EGFR Mutated Resectable NSCLC: NeoADAURA (2021) (9)
- LONG‐TERM FOLLOW UP OF PATIENTS WITH SMALL GASTROINTESTINAL STROMAL TUMORS IN THE STOMACH USING ENDOSCOPIC ULTRASONOGRAPHY‐GUIDED FINE‐NEEDLE ASPIRATION BIOPSY (2006) (9)
- Mucin-negative pseudomesotheliomatous adenocarcinoma of the lung: report of three cases. (1999) (9)
- HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells (2018) (9)
- Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion (2021) (9)
- Salvage surgery for small cell lung cancer after chemoradiotherapy (2019) (9)
- Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases. (1999) (9)
- Feasibility and Accuracy of Molecular Testing in Specimens Obtained with Small Biopsy Forceps: Comparison with the Results of Surgical Specimens (2015) (9)
- Breast carcinoma with myeloid metaplasia--a case report. (1997) (8)
- A nodal gamma/delta T-cell lymphoma with an association of Epstein-Barr virus. (1997) (8)
- Development‐dependent expression of cyclin D3 in precursor T‐cell lymphoblastic leukemia/lymphoma (2007) (8)
- Variants of adenocarcinoma (2015) (8)
- Circulating Antibodies against Epstein–Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer (2019) (8)
- PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer. (2021) (8)
- Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer. (2021) (8)
- Cutaneous Primary NUT Carcinoma With BRD3-NUTM1 Fusion. (2021) (8)
- 9002 A phase III, first-line trial of gefitinib versus cisplatin plusdocetaxel for patients with advanced or recurrent non-small cell lungcancer (NSCLC) harboring activating mutation of the epidermal growthfactor receptor (EGFR) gene: a preliminary results of WJTOG 3405 (2009) (8)
- Old Soldiers Never Die: Is There Still a Role for Immunohistochemistry in the Era of Next-Generation Sequencing Panel Testing? (2019) (8)
- Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case (2015) (8)
- You Cannot Have One without the Other (2015) (8)
- Diagnostic Ability of Percutaneous Needle Biopsy Immediately After Radiofrequency Ablation for Malignant Lung Tumors: An Initial Experience (2016) (8)
- Benign metastasizing leiomyoma of the lung: potential role of low-grade malignancy. (2009) (8)
- Analysis of ERBB4 Mutations and Expression in Japanese Patients with Lung Cancer (2010) (8)
- Pathologic Diagnosis and Genetic Analysis of a Lung Tumor Needle Biopsy Specimen Obtained Immediately After Radiofrequency Ablation (2018) (8)
- Clinical and in vitro studies of the correlation between MGMT and the effect of streptozocin in pancreatic NET (2018) (8)
- A new multiple myeloma cell line, MEF‐1, possesses cyclin d1 overexpression and the p53 mutation (1999) (8)
- Prognostic impact of the histological lepidic component in pStage IA adenocarcinoma. (2021) (8)
- Spatiotemporal T790M heterogeneity in a patient with EGFR-mutant non-small-cell lung cancer. (2014) (8)
- Lapatinib plus trastuzumab for a patient with heavily pre-treated gastric cancer that progressed after trastuzumab. (2011) (8)
- Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung (2019) (8)
- Confirmation of NKX3-1 Expression in EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma Using Monoclonal Antibody Immunohistochemistry, RT-PCR, and RNA In Situ Hybridization. (2021) (8)
- Image-guided core needle biopsy in the diagnosis of malignant lymphoma: comparison with surgical excision biopsy. (2020) (8)
- A first report of tumor cell implantation after EMR in a patient with rectosigmoid cancer. (2012) (7)
- Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts. (2012) (7)
- p 27 KIP 1 in Human Lung Cancers : Differential Changes in Small Cell and Non-Small Cell Carcinomas 1 (2006) (7)
- Epstein‐Barr virus‐related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV‐I (1997) (7)
- SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. (2021) (7)
- Genome‐wide association study of genetic factors related to confectionery intake: Potential roles of the ADIPOQ gene (2013) (7)
- Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission. (1999) (7)
- Comparison of high sensitive IHC, FISH, and RT-PCR direct sequencing for detection of ALK translocation in lung cancer. (2011) (7)
- Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy (2014) (7)
- Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody (2017) (7)
- Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of retroperitoneal schwannoma. (2010) (7)
- Hodgkin disease with subsequent transformation to CD30 positive non‐Hodgkin lymphoma in six patients (1999) (7)
- Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions (2021) (7)
- Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval. (2013) (7)
- Cigarette smoking and pancreatic cancer risk: a revisit with an assessment of the nicotine dependence phenotype. (2013) (7)
- Spontaneous regression of lung squamous cell carcinoma with synchronous mediastinal progression: A case report (2018) (7)
- Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma. (2020) (7)
- Site-specific Chemotherapy Based on Predicted Primary Site by Pathological Profile for Carcinoma of Unknown Primary Site. (2018) (7)
- Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan (2020) (6)
- Clinico-pathologic features of lung cancer with EML4-ALK translocation. (2010) (6)
- An autopsy case of primary nodal plasmacytoma associated with Sjögren’s syndrome (1999) (6)
- Molecular classification of tumors with special reference to EGFR mutation in lung cancer (2006) (6)
- Immunocytochemical detection using CDX2 (2006) (6)
- Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L). (2021) (6)
- Histological type predicts mediastinal metastasis and surgical outcome in resected cN1 non-small cell lung cancer (2017) (6)
- Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant EGFR mutant non‐small‐cell lung cancer (2018) (6)
- Identification of novel SSX1 fusions in synovial sarcoma (2021) (6)
- Epstein–Barr virus‐associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T‐cell lymphoma 9 years later: A case report of composite lymphoma (2011) (6)
- Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation (1997) (6)
- Epithelioid hemangioendothelioma of the parotid gland: a case report (2018) (6)
- IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer. (2021) (6)
- Erratum: Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms (Endoscopy (2010) 42 (1077-1084)) (2011) (6)
- An alert to possible false positives with a commercial assay for METex14 skipping. (2021) (6)
- Clinical Efficacy of Alectinib in Patients with ALK-Rearranged Non-small Cell Lung Cancer After Ceritinib Failure. (2017) (6)
- Malignant histiocytosis. A report of three cases. (1992) (6)
- Prediction of pathological margin status using preoperative contrast‐enhanced MRI in patients with early breast cancer who underwent skin‐sparing mastectomy (2019) (6)
- Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features. (2019) (6)
- Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors (2022) (6)
- Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
- Lung Cancer in Japan. (2022) (5)
- Anaplastic variant of diffuse large B‐cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics (2018) (5)
- Reassessing the SCLC Subtypes. (2020) (5)
- Phenotypic composition of salivary gland tumors: an application of principal [corrected] component analysis to tissue microarray data. (2004) (5)
- Association between CYP7A1 and the risk of proximal colon cancer in Japanese. (2010) (5)
- Reply to Letter "The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases." (2017) (5)
- 9 - Role of Thyroid Transcription Factor-1 in Pulmonary Adenocarcinoma (2002) (5)
- Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall (2022) (5)
- Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection. (2021) (5)
- Fine‐needle biopsy with 19G needle is effective in combination with endoscopic ultrasound‐guided tissue acquisition for genomic profiling of unresectable pancreatic cancer (2022) (5)
- Epithelial hyperplasia of usual type expresses both S100-alpha and S100-beta in a heterogeneous pattern but ductal carcinoma in situ can express only S100-alpha in a monotonous pattern. (1997) (5)
- Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective from the IASLC Pathology Committee. (2022) (5)
- Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis (2021) (5)
- Canadian ALK (CALK): A pan-Canadian multicenter study to optimize and standardize ALK immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for ALK gene rearrangements. (2013) (5)
- Short-term development of esophageal pyogenic granuloma observed on endoscopy. (2006) (5)
- NTRK fusion‐positive colorectal cancer in Japanese population (2021) (5)
- Distal‐type bronchiolar adenoma of the lung expressing p16INK4a – morphologic, immunohistochemical, ultrastructural and genomic analysis – report of a case and review of the literature (2020) (5)
- Minute perivascular epithelioid cell (PEC) nests in the abdominal lymph nodes—a putative precursor of PEComa (2015) (5)
- [Translational research on lung cancer--EGFR gene mutation]. (2005) (4)
- [A carcinoma arising from benign pleomorphic adenoma of the trachea]. (1997) (4)
- Targeting minimal residual disease after surgery with molecular targeted therapy: the real path to a cure? (2018) (4)
- Clinical Implications of p 53 Autoantibodies in the Sera of Patients With Non-Small-Cell Lung Cancer (1998) (4)
- Osteosarcoma with skeletal muscle metastasis (2008) (4)
- Contribution of smoking habit to the prognosis of stage I KRAS-mutated non-small cell lung cancer. (2018) (4)
- Coexisting primary early gastric plasmacytoma and sarcoidosis with hypercalcaemia (1998) (4)
- Era of comprehensive cancer genome analyses. (2014) (4)
- Evaluation of lobar lymph node metastasis in non-small cell lung carcinoma using modified total lesion glycolysis. (2018) (4)
- Mutational analysis of the EGFR gene in lung cancer with acquired resistance to gefitinib. (2006) (4)
- Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library (2021) (4)
- Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy (2018) (4)
- Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor. (2022) (4)
- Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched‐duct and mixed‐type intraductal papillary mucinous neoplasm of the pancreas (2019) (4)
- Inflammation Flare and Radiation Necrosis Around a Stereotactic Radiotherapy-Pretreated Brain Metastasis Site After Nivolumab Treatment. (2018) (4)
- Successful salvage surgery following multimodal therapy in a patient who harboured ALK‐rearranged advanced lung adenocarcinoma with multiple organ metastases (2019) (4)
- Long-term complete response in a patient with postoperative recurrent ALK-rearranged lung adenocarcinoma treated with crizotinib: A case report. (2019) (4)
- A case with primary gastric lymphoma producing IgM and IgG immunoglobulins. (1994) (4)
- Attempting to define sentinel node micrometastasis in oral squamous cell carcinoma (2020) (4)
- Nodal Relapse After Helicobacter pylori Eradication in a Patient With Primary Localized Gastric Mucosa-Associated Lymphoid Tissue Lymphoma (2011) (4)
- A case of colonic morule with colitis cystica profunda. (2007) (4)
- Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial (2022) (4)
- Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients (2018) (3)
- The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome (2017) (3)
- [Enhancement pattern of hepatic metastases from colorectal cancer on CT arteriography]. (1997) (3)
- The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC (3)
- Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma. (2016) (3)
- A Case of Gastric Cancer with Residual Tumor Only in the Para-Aortic Lymph Nodes after Systemic Chemotherapy followed by Conversion Surgery (2015) (3)
- MULTIDISCIPLINARY MANAGEMENT OF SMALL CELL CARCINOMA OF THE BREAST: A CASE REPORT (2014) (3)
- Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information (2022) (3)
- Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients (2021) (3)
- A long-term survival case of Sister Mary Joseph’s nodule caused by colon cancer and treated with a multidisciplinary approach (2019) (3)
- [Metastasis of uterine leiomyosarcoma to the pancreas--usefulness and limitations of EUS-FNA]. (2011) (3)
- Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer. (2010) (3)
- Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma (2019) (3)
- O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms (2020) (3)
- A Rare Case of Ampullary Goblet Cell Carcinoid (2018) (3)
- Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer. (2016) (3)
- The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib: A5-04 (2007) (3)
- 2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification. (2022) (3)
- Slow-growing amelanotic malignant melanoma of the esophagus with long survival: a case report and review of the literature (2017) (3)
- Clinicopathologic and Molecular Characteristics of Familial Adenomatous Polyposis–associated Traditional Serrated Adenoma (2020) (3)
- TTF-1 Immunostaining in the Diagnosis of Gastric Metastasis From Lung Adenocarcinoma. (2002) (3)
- Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients. (2021) (3)
- Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence. (2020) (3)
- Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in Mice (2019) (3)
- Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRAS. (2010) (3)
- EGFR genomic gain in Japanese non-small cell lung cancer patients treated with gefitinib. (2006) (3)
- Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan (2020) (3)
- Immunohistochemical and immunogenetic analyses of ocular adnexal lymphoid proliferation. (2000) (3)
- G-CSF-Producing Malignant Pleural Mesothelioma (2012) (2)
- ALK Expression in Small Cell Lung Cancer. (2019) (2)
- [Molecular diagnosis of lung cancer in association with treatment of choice]. (2012) (2)
- Pre-operative diagnosis of synchronous solid-pseudopapillary neoplasms of the pancreas (2010) (2)
- S6. Sentinel lymph node biopsy in early tongue cancer patients (2011) (2)
- SY1. building the foundation for investigator-initiated clinical trial (2012) (2)
- MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L‐like during epithelial‐mesenchymal transition (2021) (2)
- A case of API2-MALT1-positive gastric MALT lymphoma with concomitant diffuse large B-cell lymphoma (2017) (2)
- P2.16-34 Visceral Pleural Invasion is Closely Associated with Nodal Spread in cStage IA Lung Adenocarcinoma (2018) (2)
- Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee (2022) (2)
- [A case of anaplastic ductal carcinoma (giant cell carcinoma of osteoclastoid type) with portal vein and main pancreatic ductal invasion]. (2005) (2)
- Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach (2022) (2)
- [Clinicopathological features of 8 patients with metastatic gastric tumors]. (2012) (2)
- APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum (2021) (2)
- The overall survival of breast cancer patients without adjuvant therapy (2019) (2)
- RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma (2021) (2)
- A suture granuloma of the lung that occurred 19 years after surgery for mucoepidermoid tumor (2009) (2)
- Genomic Landscape of Atypical Adenomatous Hyperplasia and Their Progression to Lung Adenocarcinomas (2017) (2)
- Non-Hodgkin's lymphoma followed by plasmacytoma, both arising in A thyroid gland with Hashimoto's disease. (1999) (2)
- P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer (2019) (2)
- A Double Role in Lung Cancer Cell Survival? (2008) (2)
- Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization: PD6-2-2 (2007) (2)
- Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations. (2022) (2)
- [Recent changes in the therapeutic strategy for NSCLC in association with new anti-cancer agents]. (2013) (2)
- Abstract 1911: A common BIM polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer (2012) (2)
- EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence (2012) (2)
- Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non-Small Cell Lung Cancer. (2017) (2)
- Uptake of 123I-metaiodobenzylguanidine by gastrointestinal stromal tumor (2017) (2)
- Non-small cell lung carcinoma subtyping in conventional cytology: Results of the IASLC Cytology Working Group survey to determine specific cytomorphological criteria for adenocarcinoma and squamous cell carcinoma. (2022) (2)
- Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with speical reference to mantle cell lymphoma. A molecular pathologic entity (1996) (2)
- A case of metachronous left ovarian metastasis 8 years after surgery for cecal cancer and right ovarian metastasis: Report of a case (2017) (2)
- Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma. (2021) (2)
- M03-01: Molecular predictors of EGFR-TKIs (2007) (2)
- ALK-immunohistochemistry (IHC) standardization with D5F3 antibody in non-small cell lung carcinoma (NSCLC): An international consensus study. (2013) (2)
- Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report. (2011) (2)
- Anaplastic lymphoma kinase expression in small‐cell lung cancer (2019) (2)
- EGFR MutationImpact on DefinitiveConcurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma. (2015) (2)
- IL-4/CD40L Co-Stimulation Induces Long-Term Proliferation for CD10-Positive Germinal Center B Cell-Like Diffuse Large B-Cell Lymphoma (2010) (2)
- Hepatocyte growth factor as inducer of gefitinib resistance in non-small cell lung cancer harboring EGFR activating mutations. (2009) (1)
- 8005 ORAL MET Amplification is a Molecular Hallmark in Endometriosis-associated Ovarian Clear Cell Carcinoma and Correlates With Worse Prognosis (2011) (1)
- Smoking-related and non-smoking-related carcinogensis in adenocarcinoma of the lung (2008) (1)
- Anti-SARS-CoV-2 cellular immunity in 571 vaccinees assessed using an interferon-γ release assay (2021) (1)
- Prediction of Positive Surgical Margins in Sinonasal Tract Squamous Cell Carcinoma (2016) (1)
- Recent advances in thyroid cytology. The diagnostic accuracy of thyroid fine needle aspiration(FNA) cytology. (1997) (1)
- Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs. (2015) (1)
- Analysis of factors affecting the diagnostic yield of image-guided percutaneous core needle biopsy for peritoneal/omental lesions (2021) (1)
- A CASE OF LOW-GRADE B-CELL LYMPHOMA OF MUCOSA-ASSOCIAT-ED LYMPHOID TISSUE (MALT) OF THE RECTUM APPEARING TYPE IIa+IIc EARLY CANCER (1996) (1)
- Precision cancer genome testing needs proficiency testing involving all stakeholders (2022) (1)
- Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee. (2022) (1)
- Prognostic Value Of GELF Criteria and FLIPI2 For Newly Diagnosed Follicular Lymphoma Receiving R-CHOP Chemotherapy (2013) (1)
- 9142 A phase II study of gefitinib monotherapy as first-line treatment for elderly patients with stage IIIB/IV adenocarcinoma of the lung (2009) (1)
- Combination of High Serum Lactate Dehydrogenase Levels at the Time of First Diagnosis and Progression Predicts Early Lymphoma Related Death in Patients with Follicular Lymphoma Receiving R-CHOP Regimen (2014) (1)
- Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus (2014) (1)
- Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma (2022) (1)
- [Molecular diagnosis of solid tumors]. (2005) (1)
- Mucosa-associated Lymphoid Tissue Lymphoma(MALToma). (1993) (1)
- Colorectal Liver Metastases Associated with Portal, Intrabiliary Tumor Thrombus and Peri-Choledochal Nodal Involvement: A Case Report (2009) (1)
- Tumor size in patients with severe pulmonary emphysema might be underestimated on preoperative CT (2021) (1)
- Abstract 718: Acquired epithelial-mesenchymal transition like feature in anEGFR-mutant lung cancer cell line with acquired resistance to erlotinib (2011) (1)
- A useful scoring system for breast cytology diagnosis corresponding to the development of imaging modalities (2010) (1)
- Sporadic and Familial Adenomatous Polyposis-associated Foveolar-type Adenoma of the Stomach (2022) (1)
- Alectinib for Miliary Lung Metastasis in ALK-Positive Lung Adenocarcinoma (2021) (1)
- Additional Midline Biopsies of the Peripheral Zone Associated with the First Endorectal Standard Sextant Pattern Improves the Accuracy of Prostate Cancer Detection in Japanese Patients (2015) (1)
- Abstract B116: Association between CYP7A1 loci and the risk of proximal colon cancer in the Japanese (2010) (1)
- Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ. (2022) (1)
- [Long-term outcome in patients with gastric MALT lymphoma after H. pylori eradication]. (2005) (1)
- Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma (2022) (1)
- Abstract 4468: Cripto-1 elicits innate resistance to EGFR inhibitors in non-small cell lung cancer harboring EGFR-sensitizing mutations. (2013) (1)
- Adenocarcinoma in situ and minimally invasive adenocarcinoma in lungs of smokers: image feature differences from those in lungs of non-smokers (2021) (1)
- A CASE OF CAP POLYPOSIS CURED BY H. PYLORI ERADICATION THERAPY (2008) (1)
- Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma. (2012) (1)
- Clinical usefulness of PET/MRI in differentiating anterior mediastinal masses (2021) (1)
- Establishment and validation of prognostic nomograms including HER2 status in metastatic gastric cancer. (2016) (1)
- Identifying patients with peripheral-type early non-small cell lung cancer (T1N0M0) for whom irradiation of the primary focus alone could lead to successful treatment. (2008) (1)
- [A case of highly advanced gastric cancer with peritoneal dissemination -- a histological CR to S-1 and CDDP combination chemotherapy]. (2015) (1)
- Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: An epidemiological evaluation in Japan (2006) (1)
- Positive Correlation Between the Number of Circulating Tumor Cells in the Pulmonary Vein and Tumor Spread Through Air Spaces in Resected Non-small Cell Lung Cancer (2021) (1)
- Reply to P. Kaul et al. (2021) (1)
- Gene Expression Profiling of Age-Related Epstein-Barr Virus (EBV)-Associated B-Cell Lymphoproliferative Disorder Uncovers Alterations in Immune and Inflammatory Genes: Possible Implications for Pathogenesis, (2011) (1)
- GLOBAL MAPPING PROJECT – APPLICATIONS AND DEVELOPMENT OF VERSION 2 DATASET (2012) (1)
- Differences between Follicular Variant and Conventional Papillary Thyroid Carcinoma According to Fine-Needle Aspiration Cytology (2018) (1)
- P3.01-021 Reproducibility of Comprehensive Histologic Assessment and Refining Histologic Criteria in P Staging of Multiple Tumor Nodules: Topic: Morphology (2017) (1)
- Evaluation of BRAF mutation as a powerful prognostic factor in advanced and recurrent colorectal cancer. (2011) (1)
- Clinical application of a highly sensitive digital PCR assay to detect a small fraction of IDH1 R132H-mutant alleles in diffuse gliomas (2022) (1)
- Expert consensus recommendations on biomarker testing in metastatic and non-metastatic non-small cell lung cancer in Asia. (2022) (1)
- Lung Adenocarcinoma Coexistent with Pulmonary Non-tuberculous Mycobacteriosis (2012) (1)
- Senile EBV+ B-Cell Lymphoproliferative Disorders (2002) (1)
- M1441: Clinical Effectiveness of Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) for Diagnosis of Pancreatic Neuroendocrine Tumors (PNETs) (2010) (1)
- Lung cancer biomarker tests: the history and perspective in Japan (2020) (1)
- Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer (2022) (1)
- Roles of ASH1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer (2008) (1)
- Chemosensitivity and clinical features of EML4-ALK-positive patients with advanced non-small cell lung cancer. (2012) (1)
- Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers (2021) (1)
- The location of colorectal cancer (right- vs. left-sided colon and rectum) affects the prevalence of BRAF V600E, non-V600E and PIK3CA mutations: a prospective registration study in the Aichi Cancer Network (2016) (1)
- P3-106: Analysis of the relationship between the mutations of the EGFR and response to gefitinib treatment in patients with recurrent lung cancer after pulmonary resection; updated analysis (2007) (1)
- Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations (2021) (1)
- Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation Therapy (2012) (1)
- PTEN/p-AKT expression as predictive markers for cetuximab in colorectal cancer. (2010) (1)
- Simultaneous resections of left lung cancer and esophageal schwannoma using video‐assisted thoracoscopic surgery: A case report (2019) (1)
- Intraclonal microheterogeneity of mucosa‐associated lymphoid tissue lymphoma with a multiple lymphomatous polyposis appearance in the gastrointestinal tract (2001) (1)
- P-648 EGFR and Ki-ras mutations in pulmonary adenosquamous carcinoma (2005) (1)
- Assessment of Resectability of Mediastinal Germ Cell Tumor Using Preoperative Computed Tomography (2022) (0)
- Abstract 3082: TGF-β synergistically stimulates malignant mesothelioma growth with defects in the Hippo pathway by inducing CTGF expression (2012) (0)
- PD6-2-2: Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization (2007) (0)
- Analysis of biomarkers (P PTEN, and IGF-IR) after preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER2-overexpressing breast cancer (Tokai Breast Cancer Clinical Research Group: TBCRG) (2008) (0)
- Lung Adenocarcinoma with Discordant Results for ALK Based on Immunohistochemistry (IHC) Versus Fluorescence in SITU Hybridization (FISH): A Case Report (2012) (0)
- Clinicopathologic study of malignant lymphoma immunohistochemically showing cyclin D1 protein overexpression with special reference to mantle cell lymphoma (1995) (0)
- [Application of Liquid Biopsy for Lung Cancer Treatment.] (2016) (0)
- MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples (2021) (0)
- A Case of Autoimmune Pancreatitis Whose FDG Accumulation Was Markedly Decreased After Steroid Therapy (2009) (0)
- Clinical features in surgically treated patients with small cell lung cancer: Risk of brain metastasis and possible role of prophylactic cranial irradiation. (2010) (0)
- MO39-4 An association between p16/MTAP status and the efficacy of cisplatin-plus-pemetrexed or nivolumab treatment of MPM (2022) (0)
- IL-4 / CD 40 L Co-Stimulation Induces Long-Term Proliferation for CD 10-Positive Germinal Center B Cell-Like Diffuse Large B-Cell Lymphoma (2010) (0)
- Diagnostic yield of nonfunctional pancreatic neuroendocrine tumor using endoscopic ultrasound-guided fine needle aspiration biopsy. (2009) (0)
- Corrigendum to: Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma. (2020) (0)
- Clinical Characteristics of Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions (2021) (0)
- 1809P Development and validation of a deep learning model using biomarkers in pleural effusion for prediction of malignant pleural mesothelioma (2018) (0)
- 448PD Association between EGFR T790M status and progression patterns during initial EGFR-TKIs treatment in patients harboring EGFR mutation (2016) (0)
- Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia (2022) (0)
- Clinical Impact of KRAS Gene Mutation Analysis, in EUS-FNA Specimens From Pancreatic Mass Lesions (2011) (0)
- 473PDriver oncogene status in early-emerging lung adenocarcinoma (2015) (0)
- Prognostic and Predictive Implication of Epidermal Growth Factor Receptor Gene Mutation on Overall Survival in Non-Small Cell Lung Cancer Patients With Postsurgical Recurrence (2013) (0)
- Is serum HER2-ECD testing significant for resectable gastric cancer? (2015) (0)
- Clinicopathological features and response to platinum-based chemotherapy (PBC) in pancreatic neuroendocrine carcinoma (pNEC): Updated results of Japan pNEC study. (2016) (0)
- Biopsy of palliative lesions following radiotherapy (2019) (0)
- 458PComparisons of clinicopathological findings of ALK positive and EGFR positive adenocarinoma (2015) (0)
- [Pathological diagnosis of malignant lymphoma]. (2001) (0)
- Distant disease-free survival (DDFS) discrimination capacity of various pathologic complete response (pCR) definitions according to breast cancer subtypes. (2013) (0)
- A Case of Recurrent Pulmonary Artery Intimal Sarcoma After Left Pneumonectomy (2015) (0)
- Human Cancer Biology Role and Relevance of TrkB Mutations and Expression in Non – Small Cell Lung Cancer (2011) (0)
- Array CGH Analysis Reveals Amplification of Met and AKT2 in Clear Cell Carcinoma of the Ovary (2012) (0)
- LKB 1 gene mutations are infrequent in Japanese patients with lung cancer (2015) (0)
- Clinicopathological features and response to platinum-based chemotherapy in pancreatic neuroendocrine carcinoma: A retrospective multicenter study of 70 patients. (2016) (0)
- Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients. (2015) (0)
- Abstract 1209: Detection of EGFR T790M mutation in non-small-cell lung cancer patients using colony hybridization assay (2012) (0)
- Development of an assay for KRAS mutation as a predictive marker for cetuximab in colorectal cancer. (2016) (0)
- Mo1133 Anti-Viral Antibodies in Epstein-Barr Virus (EBV) Positive and Negative Gastric Cancer (2014) (0)
- Histological diagnosis for the specimen of needle biopsy immediately after lung radiofrequency ablation (2016) (0)
- Subject Index Vol. 11, Suppl. 2, 2011 (2011) (0)
- MA17.02 Visualization of Patterns of Lymph Node Metastases in Non-Small Cell Lung Cancer Using Network Graph Analysis (2021) (0)
- [Pathological and Molecular Biological Classification of Small Cell Lung Cancer]. (2021) (0)
- Liposarcoma With Hibernoma-like Histology (2022) (0)
- METex14 Skipping Testing Guidance for Lung Cancer Patients: The Guidance from the Biomarker Committee, the Japan Lung Cancer Society (2021) (0)
- Clinicopathological Study of Intraductal Papillary-Mucinous Neoplasm (IPMN) of the Pancreas with Long-Term Follow-Up (2006) (0)
- OS1. gastric cancer (2012) (0)
- 1321PIMAGING CHARACTERISTICS ASSOCIATED WITH DRIVER MUTATIONS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER. (2014) (0)
- P Development and validation of a deep learning model using biomarkers in pleural effusion for prediction of malignant pleural mesothelioma (2018) (0)
- 426P Combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas (2016) (0)
- Immunohistochemical Expression of Cyclin D1 in Relation to Prognosis among 208 Cases of Primary,Resected Non-Small Cell Lung Cancer (1996) (0)
- Safety and Effectiveness of Cell-Free Concentrated Ascites Reinfusion Therapy in Gastric Cancer Patients with Refractory Ascites (2017) (0)
- MA04.04 The Ground-Glass Component Status Combined with the Clinical T Descriptor Predicts Prognosis and Genomic Alterations in NSCLC (2022) (0)
- OA06.04 Constructing a Global Molecular Database for Thoracic Malignancies: The IASLC Molecular Subcommittee Lung Cancer Dataset (2021) (0)
- P1.06-01 Adjuvant Osimertinib vs Placebo in Completely Resected Stage IA2-IA3 EGFR-mutated NSCLC: The ADAURA2 Phase III Study (2022) (0)
- Cytological findings of acinic cell tumor of the parotid gland. A case report. (1993) (0)
- Volatolomic signatures of anaplastic lymphoma kinase gene rearrangement in adenocarcinoma: 12P (2016) (0)
- Chemosensitivity in Malignant Mesothelioma; Future Strategy (2009) (0)
- P59.11 Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan (2021) (0)
- WITHDRAWN: Rapid and dramatic response to alectinib in an ALK rearranged NSCLC patient with poor performance status and disseminated intravascular coagulation (2015) (0)
- with the liquid biopsy efficiency in NSCLC patients Association between EGFR T790M status and progression patterns during initial EGFR-TKIs treatment in patients harboring EGFR mutation (2016) (0)
- EP02.03-016 Dynamics of Recurrence After Curative Resection of Non-small Cell Lung Cancer (2022) (0)
- 124P Phase II study of neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage IIIA-B N2 non-small cell lung cancer: SQUAT trial (WJOG 12119L) (2022) (0)
- PUB032 Surgical Management of cN1 Non-Small Cell Lung Cancer: Histological Impact on Nodal Status and Survival Outcomes (2017) (0)
- Satellite Symposia (2015) (0)
- [Immunohistochemical and immunogenetic analysis of ocular adnexal lymphoid proliferations]. (1997) (0)
- Recent advances in breast cancer (2016) (0)
- Simultaneous comparison of multiple molecules using tissue array analysis in the thyroid neoplasm (2008) (0)
- Visualization of patterns of lymph node metastases in non–small cell lung cancer using network analysis (2022) (0)
- Quality control of fine needle biopsy cytology of lymph node, especially for improvement of inadequate specimen rate (2010) (0)
- 449PCurrent outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer (2017) (0)
- Molecular Pathology of the Lung Cancer -Molecular Classification of Lung Cancer Based on Expression Profile- (2007) (0)
- Sa1533 Value of Endoscopic Ultrasonography (EUS) and Endoscope Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) for Histological Diagnosis and Assessment of Malignancy of Pancreatic Neuroendocrine Tumors (pNETs) (2012) (0)
- Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (2021) (0)
- Pretreatment FDG-PET metrics to predict survival in locally advanced non-small cell lung cancer treated with definitive thoracic radiotherapy or concurrent chemoradiotherapy. (2016) (0)
- 676PPD-L1 immunohistochemistry (IHC) by three different assays and molecular profiling in tissue microarray (TMA) of gastric cancer (2017) (0)
- Abstract 3995: Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, effectively inhibits growth of patient-derived xenograft model with CIC-rearranged sarcoma (2023) (0)
- Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions. (2023) (0)
- Clinicopathological features of thymoma with the expression of programmed death-ligand 1. (2018) (0)
- Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD (2018) (0)
- Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria (2017) (0)
- Consistency and prognostic value of preoperative staging and postoperative pathological staging using18F-FDG PET/MRI in patients with non-small cell lung cancer (2022) (0)
- A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor (2023) (0)
- 3068 Impact of total lesion glycolysis at pretreatment FDG PET/CT on response duration of EGFR-TKIs in advanced NSCLC harboring EGFR mutation (2015) (0)
- ASO Visual Abstract: Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma (2022) (0)
- Keratin‐positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour (2023) (0)
- [A Case of Intrascrotal Liposarcoma]. (2016) (0)
- iprocal and Complementary Role of MET Amplification EGFR T 790 M Mutation in Acquired Resistance R inase Inhibitors in Lung Cancer (2010) (0)
- Cyclin D 1 overexpression and mantle cell lymphoma-related lesions (1997) (0)
- Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma. (2022) (0)
- Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma (2021) (0)
- Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I non-small cell lung cancer. (2023) (0)
- Radiological precursor lesions of lung squamous cell carcinoma: Early progression patterns and divergent volume doubling time between hilar and peripheral zones. (2022) (0)
- The New WHO Classification of Thoracic Tumors (2021) (0)
- The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan. (2023) (0)
- MO1-6 Characteristics of the tissue obtained in biopsy affecting the success rate of NGS testing in advanced NSCLC patients (2022) (0)
- Invasive Mucinous Adenocarcinoma of the Lung With a Mural Nodule-like Lesion (2022) (0)
- PSY1-1 The framework of cancer precision medicine in Japan (2021) (0)
- Pathology and Genome Medicine of the Lung Cancer (2020) (0)
- Analysis of EML4-ALK Positive Non-Small Cell Lung Cancer with Advanced Stage (2012) (0)
- Radiological imaging and pathological findings of small lung adenocarcinoma: a narrative review (2021) (0)
- Abstract 84: Identification of HNRNPLL as a novel metastasis suppressor of colorectal cancer (2018) (0)
- MO9-1 Real-world data of multiple diagnostic biomarker testing for lung cancer patients in Japan (2021) (0)
- PUB015 The Use of Immunohistochemistry Improves the Diagnosis of SCLC. An International Reproducibility Study in a Demanding Set of Cases (2017) (0)
- Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer. (2019) (0)
- Mammographic and ultrasonographic findings of invasive lobular carcinoma (1996) (0)
- Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report (2022) (0)
- Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests” (2023) (0)
- Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma (2016) (0)
- Transformation to small cell lung cancer following treatment with an ALK inhibitor (2016) (0)
- Detection of EML4-ALK Fusion (2012) (0)
- A Case of Primary Cancer of the Appendix which Directly Invaded the Urinary Bladder (2006) (0)
- Rb expression and KRAS mutation as predictors of response to platinum-based chemotherapy (PBC) of small and large cell neuroendocrine carcinoma (NEC): A subgroup analysis of the Japan pNEC study (2016) (0)
- 1929 THE IMPACT OF PATHOLOGIST-DEPENDENT GLEASON SCORE VARIATIONS ON CLINICAL RISK CLASSIFICATION OF PROSTATE CANCER AFTER THE GLEASON SCORE GRADING CONSENSUS DEFINED BY THE INTERNATIONAL SOCIETY OF UROLOGICAL PATHOLOGY (ISUP: 2005) (2013) (0)
- Abstract B53: Time to first cigarette and lung cancer risk in Japan (2013) (0)
- Behavior of bone marrow-derived cells following in vivo transplantation: differentiation into stromal cells with roles in organ maintenance. (2013) (0)
- MULTIPLE INTRA-ABDOMINAL DESMOID TUMORS ORIGINATING FROM MESENTERY OF THE ASCENDING COLON AND GREATER OMENTUM WITHOUT HISTORY OF PREVIOUS SURGERY-A CASE REPORT- (2008) (0)
- 6096 Frequency of KRAS/BRAF mutations as predictive markers for Cetuximab in Japanese colorectal cancer patients (2009) (0)
- Abstract 2185: MicroSEC: Sequence error filter for formalin-fixed and paraffin-embedded samples (2022) (0)
- CLINICOPATHOLOGIC STUDY OF CYCLIN D1-OVEREXPRESSING LYMPHOMA (1997) (0)
- P1.03-044 EUS-Guided Sampling of Mediastinal Lymph Nodes and Abdominal Lesions in Lung Cancer: Topic: Screening (2017) (0)
- A case of intrapulmonary solitary fibrous tumor harboring NAB2-STAT6 fusion gene (2019) (0)
- O-79 Prognostic model of pulmonary adenocarcinoma by expression profiling as determined by quantitative real-time PCR (2003) (0)
- [Pathological Diagnosis of MSI-H Tumors]. (2018) (0)
- LKB1 gene mutations are infrequent in Japanese patients with lung cancer: P2-021 (2007) (0)
- 455PDifferential crizotinib response duration among ALK fusion variants in ALK-positive NSCLC (2015) (0)
- [Lung cancer: progress in diagnosis and treatments. Topics: II. Diagnosis and examination; 3. Pathological diagnosis, molecular testing and biomarkers]. (2014) (0)
- Activating Mutations − Receptor Lung Adenocarcinoma with Epidermal Growth Factor Hepatocyte Growth Factor Induces Gefitinib Resistance of Updated (2008) (0)
- Abstract 4762: ITPKA expression in lung and other cancers, regulated via gene body methylation, functions as an oncogene (2015) (0)
- Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delay. (2021) (0)
- Abstract 3429: Genetic analysis of pancreatic neuroendocrine neoplasms grade 3 (2019) (0)
- Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features (2019) (0)
- Distinct Hematolymphoid Disease Entity Myeloid/Natural Killer Cell Precursor Acute Leukemia: A + and CD56 + CD7 (2011) (0)
- 205PDevelopment of nomograms including HER2 status for predicting survival in metastatic gastric cancer (2015) (0)
- P1.08-032 Impact of the Oncogenic Status on the Mode of Recurrence in Resected Non-Small Cell Lung Cancer: Topic: Translational Studies (2017) (0)
- Reply to the Letter to the Editor From He Y et al. (2023) (0)
- O1-12-5Examination about the correlation of MGMT expression and effect of streptozocin in gastroenteropancreatic NET (2017) (0)
- Morphological Features of the Most Advanced Intra-Tumor Component in Multistep Progression (2010) (0)
- Minimally invasive adenocarcinoma (2015) (0)
- Abstract 1120: Role and relevance of TrkB mutations and expression in non-small cell lung cancer (2011) (0)
- Accumulation of FDG Due to Autoimmune Pancreatitis Distinctly Decreased After Steroid Therapy (2010) (0)
- Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules (GGN): Differences between those with growth potential and those without. (2014) (0)
- 474PEffects of smoking habit in NSCLC with KRAS mutation in pathological stage I (2015) (0)
- Analysis of K-ras point mutation in pancreatic mass lesions using endoscopic ultrasonography-guided fine needle aspiration (2009) (0)
- A Resected Case Difficult in Distinguishing Invasive Adenocarcinoma Derived From IPMN From Usual Pancreatic Cancer Coexisting With IPMN- Introduction of Genomic Exploration - (2009) (0)
- Updates in the 5th Edition of the WHO Classification of Thoracic Tumors (2022) (0)
- ES17.06 Updates in Molecular Pathology and Genomics of Lung Tumors (2021) (0)
- Effect of duration from initial diagnosis on the frequency of T790M secondary mutation after EGFR-TKI failure in EGFR-mutant lung adenocarcinomas. (2016) (0)
- Diagnostic pitfalls on aspiration cytology of salivary gland.Diagnostic pitfalls on aspiration cytology of salivary gland. Salivary gland lesion with prominent lymphoid cell infiltration: Differential diagnosis and pitfalls. (2002) (0)
- Two Cases of Non-Small-Cell Lung Cancer with Tonsillar Metastasis. (1996) (0)
- RELATIONSHIP BETWEEN PROGNOSIS AND NODAL MICROMETASTASIS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (2006) (0)
- Nivolumab Enhances the In fl ammation of the Irradiation Field in Advanced Non – Small Cell Lung Cancer (0)
- Abstract 2014: Gene expression profiling identifies characteristic oncogenetic pathways in age-related Epstein-Barr virus (EBV)-positive B-cell lymphoproliferative disorders. (2013) (0)
- Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma (2016) (0)
- Abstract A178: Role of tumor and host‐derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation‐positive lung cancer (2009) (0)
- AOSOP14 MATRIX-PRODUCING CARCINOMA OF THE BREAST: IMMUNOHISTOCHEMICAL EXPRESSION PROFILES OF A RARE SUBTYPE OF BREAST CARCINOMA (2013) (0)
- Surgery for pancreatic neuroendocrine carcinoma (pNEC): A subgroup analysis of Japan pNEC study (2016) (0)
- P-179POST-RECURRENT SURVIVAL OUTCOMES ACCORDING TO THE ONCOGENIC STATUS IN PATIENTS WITH RESECTED NON-SMALL CELL LUNG CANCER (2016) (0)
- A Case of Invasive Ductal Carcinoma of the Pancreas With a Cyst Lacking an Ovarian-Like Stroma (2009) (0)
- A Pilot Proficiency Testing Study for Assessing Cancer Gene Panel using Patient Samples and Next-generation Sequencing in Japan (2021) (0)
- 966PMANAGEMENT AND LONG-TERM CLINICAL OUTCOME OF API2-MALT1 POSITIVE GASTRIC MALT LYMPHOMA. (2014) (0)
- P04.07 Long-term Postoperative Prognosis of Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma of Lung (2021) (0)
- Survival outcome of metastatic adenocarcinoma of esophagogastric junction in the trastuzumab era. (2016) (0)
- EP1.14-44 Lung Adenocarcinoma with a Rare BRAF V600E K601_W604del Mutation Responded to Dabrafenib Plus Trametinib Treatment: A Case Report (2019) (0)
- EGFR mutations in non-small-cell lung cancer – Authors' reply (2010) (0)
- Phenotypic composition of salivary gland tumors: an application of principal component analysis to tissue microarray data (2004) (0)
- Trastuzumab for a patient with heavily pretreated gastric cancer plus massive ascites and ovarian metastasis. (2012) (0)
- O3-15-4Development of nomograms for predicting survival in advanced gastric cancer (2015) (0)
- Abstract 4808: Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. (2013) (0)
- Metastasised Sarcomatoid Carcinoma Component with a Rare BRAF K601E Point Mutation and High PD-L1 Expression (2018) (0)
- Immunohistochemical and cytopathological analyses of adenoid cystic carcinoma of the salivary glands (2006) (0)
- RELATIONSHIP BETWEEN MALT LYMPHOMA OF THE STOMACH AND HELICOBACTER PYLORI INFECTION (1996) (0)
- Molecular pathology quality control in Southeast Asia: Results of a Multiregional Quality Assurance Study from MASTER KEY Asia. (2023) (0)
- 46PDThe solid component evaluated on computed tomography can predict the invasiveness and lymph node metastasis in lung adenocarcinoma as well as pathological invasive size (2017) (0)
- Abstract P2-01-09: Circulating tumor cells (CTCs) in the venous drainage of the breast in patients with primary breast cancer (2018) (0)
- Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2. (2023) (0)
- KLF4 c.A1322C Mutation Is a Consistent and Specific Genetic Feature of Raspberry-like Foveolar-type Adenoma of the Stomach. (2022) (0)
- ES12.02 Invasive Mucinous Adenocarcinoma (2019) (0)
- EGFR mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma (2009) (0)
- Impact of age for overall survival in head and neck sarcoma (2020) (0)
- Abstract 441: Functional characterization of recurrent CD74‐NRG1 fusions in lung adenocarcinoma (2014) (0)
- Features of prognosis, genetics and drug sensitivity of very elderly lung cancer patients. (2015) (0)
- CLINICOPATHOLOGIC STUDY OF BLASTIC NATURAL KILLER-CELL LYMPHOMA (1997) (0)
- A case of second primary lung cancer diagnosed by surgical resection at salvage setting (2018) (0)
- P3-9-7A patient with primary right iliac carcinosarcoma who improved with chemo-radiation (2015) (0)
- Abstract IA5: Genetic and genomic difference in lung cancer based on ethnicity (2012) (0)
- A mimic of lung adenocarcinoma: a case report of histological conversion of metastatic thyroid papillary carcinoma (2021) (0)
- Alcohol Drinking, Smoking, Past History of Gastroduodenal Ulcer, Height, and Risk of API2-MALT1 Fusion Positive and Negative Gastric MALT Lymphoma Among Japanese. (2009) (0)
- Real-world study of next-generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan. (2023) (0)
- Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine (2022) (0)
- P1.07-007 Clinical Outcomes of Patients with LS-SCLC Treated with Chemoradiotherapy. Can We Find Candidates for Salvage Surgery?: Topic: Drug Treatment Alone and in Combination with Radiotherapy (2017) (0)
- P3.01-023 Quality Assessment of Resampling Specimens in Primary Lung Cancers with Acquired Resistance to the Initial Therapy: Topic: Morphology (2017) (0)
- A process for classifying the strength of gene expression in lung cancer tissues. (2004) (0)
- cyclin D1-negative MCL-like B-cell lymphoma lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and Significance of cyclin D1 overexpression for the diagnosis of mantle cell (2013) (0)
- Thyroid transcription factor 1 expression in endometrioid tumors: a note of caution—reply (2011) (0)
- Survival of patients with HER2-positive gastric cancer with introduction of trastuzumab. (2012) (0)
- Not like breast cancer, but like breast cancer: micrometastasis and micropapillary structure in lung cancer. (2017) (0)
- Aggressive carcinoid tumors arising in the duodenum, ileum, and rectum with liver metastasis: a report of three cases. (2008) (0)
- MA08.08 Implementation of Diagnostic Biomarker Testing in Lung Cancer: Real-World Data in Japan (2021) (0)
- Abstract 277: Multiplex Epstein-Barr virus (EBV) serology in EBV-positive and -negative gastric cancer (2014) (0)
- 3069 Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients (2015) (0)
- [Gastric MALT lymphoma is one of the diseases for which H. pylori eradication is recommended]. (2005) (0)
- Liquid Biopsy in Lung Cancer. (2016) (0)
- Precision cancer genome testing needs proficiency testing involving all stakeholders (2022) (0)
- PRESENT STATUS OF ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION IN JAPAN (2008) (0)
- Clinicopathological analysis of endometrial carcinoma undiagnosed by curettage (2015) (0)
- A Case of Recurrent Thymic Atypical Carcinoid with Pleural and Peritoneal Dissemination Six Years After Thymectomy (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yasushi Yatabe?
Yasushi Yatabe is affiliated with the following schools:
- Kyoto University
- University of Helsinki
- Hokkaido University
- University of Texas Medical Branch
- Kyushu University
- University of Cologne
- Kanazawa University
- University of Tokyo
- Icahn School of Medicine at Mount Sinai
- University of Southern California
- University of Tsukuba
- Nagoya University
- Gunma University
- Osaka University
